Hallo Rudolf,
ein vielleicht interessanter Vergleich zwischen Cabazitaxel und Abiraterone bei Pts. post Tax-Chemo:
"..In patients treated with cabazitaxel, after 3 months of therapy the PSA reduction rate >50% was 46.2%, the PSA progression rate was 15.4%, and the disease control rate was 83.3%.
...
In patients treated with abiraterone, after 3 months of therapy the PSA reduction rate >50% was 35.1%, the PSA progression rate was 46.0%, and the disease control rate was 47.1%..."
ein vielleicht interessanter Vergleich zwischen Cabazitaxel und Abiraterone bei Pts. post Tax-Chemo:
"..In patients treated with cabazitaxel, after 3 months of therapy the PSA reduction rate >50% was 46.2%, the PSA progression rate was 15.4%, and the disease control rate was 83.3%.
...
In patients treated with abiraterone, after 3 months of therapy the PSA reduction rate >50% was 35.1%, the PSA progression rate was 46.0%, and the disease control rate was 47.1%..."
Kommentar